Capital Group Global Equity Fund (LUX) ZLdRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 15.7 | -5.1 | 11.4 | 8.4 | |
+/-Cat | - | -2.3 | 4.3 | -1.4 | -1.4 | |
+/-B’mrk | - | -3.9 | 2.6 | -3.9 | -4.3 | |
Category: Global Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar Global TME NR USD |
Key Stats | ||
NAV 25/10/2024 | USD 52.66 | |
Day Change | -0.41% | |
Morningstar Category™ | Global Large-Cap Blend Equity | |
ISIN | LU2099028859 | |
Fund Size (Mil) 25/10/2024 | USD 665.48 | |
Share Class Size (Mil) 25/10/2024 | USD 28.11 | |
Max Initial Charge | 5.25% | |
Ongoing Charge 26/01/2024 | 0.68% |
Investment Objective: Capital Group Global Equity Fund (LUX) ZLd |
Long-term capital growth through investment primarily in listed Equity, researched and selected on a world-wide basis. Unlisted securities may also be purchased, subject to the relevant provisions of the "General Investment Guidelines and Restrictions". |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Philip Winston 22/01/2020 | ||
William Robbins 22/01/2020 | ||
Click here to see others | ||
Inception Date 24/01/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR USD | Morningstar Global TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Capital Group Global Equity Fund (LUX) ZLd | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Broadcom Inc | Technology | 2.75 |
Novo Nordisk AS Class B | Healthcare | 2.52 |
Microsoft Corp | Technology | 2.33 |
Apple Inc | Technology | 2.15 |
AstraZeneca PLC | Healthcare | 2.04 |
Increase Decrease New since last portfolio | ||
Capital Group Global Equity Fund (LUX) ZLd |